Suppliers / Dijia Pharmaceutical Group

Dijia Pharmaceutical Group

China Updated 9 July 2026

Dijia Pharmaceutical Group is an API manufacturer based in China. It holds one active US drug master file and 3 valid CEPs across a filed portfolio of 4 molecules.

1
active US DMFs
3
valid CEPs
2
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026.

Registered plants

Site FDA FEI
Weihai, China Not on file
China, China 3011998304

What they file, and where

Molecule Regulators Docs
Glipizide US FDA 1
Rivaroxaban EDQM 1
Solifenacin Succinate EDQM 1
Terazosin EDQM 1

Also appears on these molecule pages

Glipizide API Terazosin API Rivaroxaban API Solifenacin API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None

Questions about Dijia Pharmaceutical Group

Does Dijia Pharmaceutical Group hold a US DMF or a CEP?
Dijia Pharmaceutical Group holds 1 active US drug master file and 3 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Dijia Pharmaceutical Group FDA-registered?
One site operated by Dijia Pharmaceutical Group carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
Where does Dijia Pharmaceutical Group manufacture?
2 registered sites are on record, in China (Weihai and China). Every site is listed on this page with the register it came from.
What does Dijia Pharmaceutical Group make?
4 molecules are on record against Dijia Pharmaceutical Group, including Glipizide, Rivaroxaban, Solifenacin Succinate and Terazosin. Each links through to that molecule's full manufacturer list.
Where does Dijia Pharmaceutical Group file?
Filings are on record with MINSA (CR), 1 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Checking Dijia Pharmaceutical Group?

Ask Fred what the record holds on Dijia Pharmaceutical Group, including filings and inspection history.

Chat with Fred, your AI analyst
Opens WhatsApp. Free to start.

Comparable suppliers

Apitoria Pharma shares 1 molecule Olon shares 1 molecule Jubilant Biosys shares 1 molecule Biophore India Pharmaceuticals shares 1 molecule Cambrex Profarmaco Milano shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability